MIT invests Rs 198 cr in Medi Assist

Medi Assist Healthcare Services has received a Rs 198 crore investment from the Massachusetts Institute of Technology ( MIT ) and 238 Plan Associates, an MIT affiliate, through a preferential allotment on a private placement basis. The Bengaluru-based health benefits administrator, which is India's largest, issued 37,01,000 fully paid-up equity shares of Rs 5 each at Rs 535 per share.



The board cleared the allotment on Aug 7, 2025, and shareholders approved it on Sept 4, with 99.15% of votes in favour. The investment comes soon after Medi Assist’s acquisition of Fairfax-owned Paramount Health Services & Insurance TPA in July and its technology partnership with Star Health Insurance in June. The company said the funds would strengthen its capital base and support growth driven by technology and innovation.



“This investment from MIT unequivocally reaffirms Medi Assist’s mission to spearhead India’s digital health transformation,” said CEO Satish V N Gidugu. “Technology remains at the core of our operations, enabling us to make healthcare simpler, faster, and more transparent.” He added that the company aims to “accelerate innovation in AI-led health benefit solutions that improve member experience and payer outcomes.”



Medi Assist provides health benefits administration and technology services to insurers, hospitals, corporates, and Govt health schemes through its subsidiaries Medi Assist TPA and Paramount Health Services & Insurance TPA. The company is listed on NSE and BSE.



238 Plan Associates is a Massachusetts-based investment entity affiliated with MIT and registered with SEBI as a Foreign Portfolio Investor. It typically invests in Indian companies as a qualified institutional buyer, often taking anchor positions in IPOs and preferential allotments. The entity manages investments on behalf of MIT’s employee benefit plans, including the MIT Basic Retirement Plan Trust and MIT Welfare Benefit Plan Trust.



It is not a standalone fund but a vehicle for deploying MIT’s benefit plan capital in global markets. Its investments in India, such as the Rs 43.3 crore stake in Medi Assist earlier this year, are part of a strategy that focuses on high-quality assets with sound fundamentals. The entity follows a conservative, long-term investment approach, prioritizing risk diversification, regulatory compliance, and sustainable value creation for MIT’s beneficiaries.